KRAS-Mutant Colorectal Cancer Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About KRAS-Mutant Colorectal Cancer
Colorectal cancer (CRC) is a significant health concern, and understanding its specific characteristics is crucial for effective treatment. One such characteristic is the presence of a *KRAS mutation*. KRAS is a gene that plays a key role in cell growth and division. When it mutates, it can lead to uncontrolled cell proliferation, contributing to cancer development and progression.
Approximately 30-50% of colorectal cancers
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.